Item 16. FORM 10-K SUMMARY
4K characters. Original on sec.gov ·
Item 16. FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| INTUITIVE SURGICAL, INC. | ||||||||
| By: | /S/ GARY S. GUTHART | |||||||
| Gary S. Guthart, Ph.D. President and Chief Executive Officer |
Date: February 9, 2021
Power of Attorney
Each person whose individual signature appears below hereby authorizes and appoints Gary Guthart, Ph.D., and Marshall Mohr, and each of them, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place, and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this annual report on Form 10‑K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /S/ GARY S. GUTHART | President, Chief Executive Officer, and Director (Principal Executive Officer) | February 9, 2021 | ||||||||||||
| Gary S. Guthart, Ph.D. | ||||||||||||||
| /S/ MARSHALL L. MOHR | Executive Vice President and Chief Financial Officer (Principal Financial Officer) | February 9, 2021 | ||||||||||||
| Marshall L. Mohr | ||||||||||||||
| /S/ JAMIE E. SAMATH | Senior Vice President, Finance (Principal Accounting Officer) | February 9, 2021 | ||||||||||||
| Jamie E. Samath | ||||||||||||||
| /S/ CRAIG H. BARRATT | Chairman of the Board of Directors | February 9, 2021 | ||||||||||||
| Craig H. Barratt, Ph.D. | ||||||||||||||
| /S/ JOSEPH C. BEERY | Director | February 9, 2021 | ||||||||||||
| Joseph C. Beery | ||||||||||||||
| /S/ AMAL M. JOHNSON | Director | February 9, 2021 | ||||||||||||
| Amal M. Johnson | ||||||||||||||
| /S/ DON R. KANIA | Director | February 9, 2021 | ||||||||||||
| Don R. Kania, Ph.D. | ||||||||||||||
| /S/ AMY L. LADD | Director | February 9, 2021 | ||||||||||||
| Amy L. Ladd, Ph.D. | ||||||||||||||
| /S/ KEITH R. LEONARD JR. | Director | February 9, 2021 | ||||||||||||
| Keith R. Leonard Jr. | ||||||||||||||
| /S/ ALAN J. LEVY | Director | February 9, 2021 | ||||||||||||
| Alan J. Levy, Ph.D. | ||||||||||||||
| /S/ JAMI DOVER NACHTSHEIM | Director | February 9, 2021 | ||||||||||||
| Jami Dover Nachtsheim | ||||||||||||||
| /S/ MARK J. RUBASH | Director | February 9, 2021 | ||||||||||||
| Mark J. Rubash |
Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULE